医疗质量对子宫内膜癌生存种族差异的影响
基于美国国家癌症数据库2004至2016年310208例子宫内膜癌患者,评估5项循证质量指标依从性与黑人和白人女性生存差异的关系。黑人女性接受循证治疗的比例较低,完美依从可改善结局但未消除种族生存差异,黑人女性死亡风险仍较高。
要点
- 黑人女性接受循证治疗的比例低于白人女性。
- 完美依从质量指标可改善黑人女性生存但未消除差异。
- 完美依从的黑人I期患者5年死亡风险仍高于白人。
核心结论
- 黑人子宫内膜癌患者接受循证治疗的比例低于白人,完美依从可减轻但未消除种族生存差异。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库2004至2016年310208例子宫内膜癌患者,其中黑人35035例(11.3%),白人275173例(88.3%)。
主要发现
- 黑人女性接受手术及时性(Q1)、微创手术(Q2)、盆腔淋巴结评估(Q3)和全身化疗(Q5)的比例均低于白人女性(P < .05)。
- I期完美依从者中白人占53.1%,黑人占41.5%;完美依从黑人I期患者30天死亡调整相对危险度2.25(95%CI 1.30-3.90),90天1.84(95%CI 1.23-2.76),5年死亡调整风险比1.42(95%CI 1.26-1.59)。
- III期完美依从者中白人占56.6%,黑人占44.1%;完美依从黑人III期患者30天死亡调整相对危险度1.86(95%CI 1.01-3.44),5年死亡调整风险比1.35(95%CI 1.22-1.50)。
关键数值与推荐
- 5项循证质量指标:诊断后6周内手术(Q1)、I-IIIC期微创手术(Q2)、高危肿瘤盆腔淋巴结评估(Q3)、高中危辅助放疗(Q4)、III-IV期全身化疗(Q5)。
临床怎么用
- 应促进子宫内膜癌患者对循证治疗指南的依从性,尤其关注黑人女性,但需认识到依从性改善不足以完全消除生存差异。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Black women experience poorer survival compared with white women across all endometrial cancer stages and histologies. The incidence of endometrial cancer is 30% lower in black women compared with white women, yet mortality is 80% higher in black women. Differences in adherence to evidence-based guidelines have been proposed to be major contributors to this disparity. OBJECTIVES: We examined whether adherence to evidence-based treatment recommendations for endometrial cancer could mitigate survival disparities between black and white women. STUDY DESIGN: The National Cancer Database was used to identify women with endometrial cancer treated from 2004 through 2016. We established 5 evidence-based quality metrics based on review of primary literature and accepted guidelines: surgical treatment within 6 weeks of diagnosis (Q1), use of minimally invasive surgery (stage I-IIIC; Q2), pelvic nodal assessment (high-risk tumors; Q3), adjuvant radiation (high intermediate risk; Q4), and systemic chemotherapy (stage III-IV; Q5). The rates of 30 and 90 day mortality and 5 year survival were compared between black and white women. To determine the influence of quality on outcomes, we compared outcomes among perfectly adherent black and white women with stage I and III endometrial cancer. RESULTS: We identified 310,208 women including 35,035 (11.3%) black women and 275,173 (88.3%) white women. Black women were less likely than white women to receive Q1 (65.8 vs 75.6%), Q2 (58.5 vs 72.9%), Q3 (71.3 vs 74.2%), and Q5 (72.7 vs 73.2%) (P < .05 for all). Adherence to each quality metrics was associated with improved survival. Among women with stage I disease, perfect adherence to the relative quality metrics was seen in 53.1% of white and 41.5% of black women. Among perfectly adherent stage I patients, outcomes in black women improved relative to unselected black women; however, they still experienced higher risk of 30 day (adjusted relative risk, 2.25; 95% confidence interval, 1.30-3.90), 90 day (adjusted relative risk, 1.84; 95% confidence interval, 1.23-2.76), and 5 year mortality (adjusted hazard ratio, 1.42; 95% confidence interval, 1.26-1.59) compared with similar white women. Among women with stage III tumors, perfect adherence to the relative quality metrics was seen in 56.6% of white and 44.1% of black women. Perfectly adherent black women with stage III disease had improved outcomes but remained at increased risk of 30 day (adjusted relative risk, 1.86; 95% confidence interval, 1.01-3.44) and 5 year mortality (adjusted hazard ratio, 1.35; 95% confidence interval, 1.22-1.50) compared with white women. CONCLUSION: Black women are less likely than white women with endometrial cancer to receive evidence-based care. However, receipt of evidence-based care mitigates but does not eliminate racial disparities in outcomes and black women remain at greater risk of death from endometrial cancer.
引用
- Huang AB, Huang Y, Hur C, et al. Impact of quality of care on racial disparities in survival for endometrial cancer. Am J Obstet Gynecol. 2020. PMID: 32109459. doi:10.1016/j.ajog.2020.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。